prolaris-patient-take-next-steps

Download a FREE patient testing guide.

Learn how Prolaris can inform better cancer treatment decisions. 

Act now, to start personalizing your prostate cancer treatment





Hidden Fields












If you would like us to provide educational information about Prolaris to your healthcare provider, include their information below






Better answers with Prolaris

Clearly and confidently understand which cancer treatment option is right for you.

Better answers with Prolaris

Clearly and confidently understand which cancer treatment option is right for you.

What is Prolaris? 

Prolaris is a prognostic test that can identify how aggressive your prostate cancer is, how fast it’s growing and what treatment options will be most effective.

Is Prolaris right for me? 

The Prolaris Prostate Cancer Prognostic test is for untreated men with prostate cancer. Testing is easy, with no additional biopsy necessary.

Download our FREE patient testing guide by filling out the form on the right-hand side.

Download our FREE patient testing guide by filling out the form on the right-hand side.

Up to 65% change in treatment

In two clinical utility studies, Prolaris results lead to change in management in up to 65% of patients.1,2,3

Easy

Easy testing with no additional biopsy required

$0

out of pocket

97% of patients pay $0

Prolaris Patient story

“Prolaris gave me the ability to maintain the lifestyle that my wife and I have lived with for many years now.”

Tim Petracca

Prolaris Patient story

“Prolaris gave me the ability to maintain the lifestyle that my wife and I have lived with for many years now.”

Tim Petracca

Myriad is here for you

Contact our trusted advisors for personalized support.

References:

  1. Crawford ED, Scholz MC, Kar AJ, et al. Cell Cycle Progression Score and Treatment Decisions in Prostate Cancer:Results From an Ongoing Registry. Curr Med Res Opin 2014; 1-7
  2. Shore, N D., et al. Impact of the cell cycle progression test of physician and patient treatment selection for localized prostate cancer. The Journal of Urology 2016;195(3),612- 618
  3. Lin, D. W., et al. Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance. Urologic Oncology: Seminars and Original Investigations. 2018; doi: 10.1016/j.urolonc.2018.03.011.
prolaris-patient-take-next-steps